Mounjaro has been involved with gastrointestinal adverse reactions, which include nausea, vomiting, and diarrhea. These activities could bring on dehydration, which if critical could cause acute kidney injuries. In sufferers treated with GLP-one receptor agonists, there have been postmarketing reports of acute kidney damage and worsening of Persist